ProMIS Neurosciences (PMN) AGM 2026 summary

Opening remarks and agenda

• Meeting chaired by the CEO, with appointments of recording secretary and scrutineer.

• Agenda included presentation of annual financial statements, election of seven directors, appointment of auditor, and approval of an amendment to the 2025 Stock Option and Incentive Plan.

Financial performance review

• Audited financial statements for the year ended December 31, 2025, and auditor's report were presented and accepted.

Board and executive committee updates

• Seven director nominees were presented, all consenting to stand for election.

• No nominations were received for persons other than those named in the proxy statement.